DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages

Koebner phenomenon

Author: Arcana Luo, Medical Student, University of Auckland, New Zealand; Chief Editor: Dr Amanda Oakley, Dermatologist, Hamilton, New Zealand, March 2014.


Koebner phenomenon — codes and concepts
open

What is the Koebner phenomenon?

The Koebner phenomenon describes the appearance of new skin lesions on areas of cutaneous injury in otherwise healthy skin. It is also known as the Köbner phenomenon and isomorphic response.

Linear lesions due to the Koebner phenomenon in lichen planus

What is the cause of the Koebner phenomenon?

The cause of the Koebner phenomenon is unclear. Current theories suggest the Koebner phenomenon requires both epidermis and dermis to be injured at the same site. The production of inflammatory substances and neuropeptides has been postulated as a non-specific first step, triggering a secondary disease-specific process. The role of chemical messengers such as nerve growth factor (NGF) may be important.

In what conditions is the Koebner phenomenon observed?

Skin conditions that regularly manifest Koebner phenomenon are psoriasisvitiligo and lichen planus. There have been reports of possible Koebner phenomenon in many other conditions.

A true Koebner response occurs in:

A pseudo-Koebner response occurs with infections arising in an area of trauma.

Localised trauma can also lead to:

What are the triggers for the Koebner phenomenon?

A variety of skin injuries have been found to trigger the Koebner phenomenon.

Trauma

Chemical irritation

Diseases/medical conditions

  • Urticaria
  • A variety of inflammatory dermatoses

Other

How is the Koebner phenomenon diagnosed?

The Koebner phenomenon is diagnosed clinically. The characteristic lesions:

  • Develop at sites of cutaneous injury (such as a scratch), in previously healthy skin
  • Have the same clinical and histological features as lesions of the patient's original skin disease
  • Are not due to the seeding of an infectious agent, an allergic reaction to a contact agent, or skin breakdown.

Lesions may form in patients with or without pre-existing skin conditions. A true Koebner response can be confirmed by experimentally reproducing lesions with different methods of injury. However, this may not always work and is not usually practical or desirable.

Koebner phenomenon lesions are often linear in shape, as they follow the route of cutaneous injury. Aside from linear skin injury, linear lesions arising from the Koebner phenomenon can also be seen in mosaic skin disorders (eg, segmental lichen planus).

What are the clinical features of the Koebner phenomenon?

Graded response to trauma

Patients differ in terms of how intensely they respond to skin injury.

  • Maximal Koebner response: lesions develop across the entire injured area.
  • Minimal Koebner response: a lesion develops in a focal area of trauma.
  • Abortive Koebner response: lesions appear, but spontaneously vanish after 12–20 days.
  • No Koebner response to injury.

All or nothing response

Patients who develop the Koebner phenomenon in response to one method of injury are susceptible to other triggering stimuli. This is particularly noted in patients with psoriasis. Conversely, a patient who does not develop skin lesions with one type of injury is not expected to exhibit the Koebner phenomenon with another type of injury.

Time to development of lesions

The time from injury to the formation of a skin lesion depends on the specific skin disease. For psoriatic plaques, it is between 10 to 20 days, with a range from 3 days to 2 years. The time to lesion formation can differ in the same patient.

Non-cutaneous Koebner phenomenon

Some reports suggest the Koebner phenomenon may affect other surfaces apart from the skin, such as the oral mucosa, or cause lesions in internal organs, such as the lungs after damage from chronic infection. Cutaneous lesions due to Koebner phenomenon have been reported in sarcoidosis and systemic lupus erythematosus.

What other phenomena are associated with cutaneous trauma?

Other phenomena in relation to trauma or skin damage are distinct from the Koebner phenomenon.

  • The reverse Koebner phenomenon is the disappearance of a skin lesion after trauma to the area.
  • Wolf's isotopic response is the emergence of new lesions in the exact place of previous, healed, lesions and is not necessarily due to trauma.
  • Renbok phenomenon is the disappearance of an existing dermatosis after the onset of a new lesion at the same location.
  • Pathergy is an altered tissue reactivity in response to trauma, with the formation of papules or pustules

Koebner phenomenon in psoriasis

Psoriasis is the most-researched condition that exhibits the Koebner phenomenon and can be used to aid diagnosis.

Koebner phenomenon has been noted to be particularly prevalent in:

  • Unstable psoriasis
  • Patients with a young age of onset of psoriasis
  • Patients who have received multiple treatments for psoriasis
  • Winter, compared to summer
  • Emotionally distressed patients.

Other studies indicate that the Koebner phenomenon:

  • Occurs less frequently during remission from psoriasis
  • Is not related to disease severity; it can occur in mild and severe disease.

Plaques exhibiting the Koebner phenomenon can appear on any area of the body, even those not usually involved by psoriasis.

In recalcitrant psoriasis, a concurrent skin condition such as contact dermatitis may drive the disease via the Koebner phenomenon.

Koebner phenomenon in psoriasis

Can the Koebner phenomenon be prevented?

Although it is not possible to prevent all cutaneous injury, if you are susceptible to the Koebner phenomenon, take care to avoid:

The following have been reported to prevent the Koebner phenomenon:

  • Pressure, such as a pressure dressing or bandage
  • Suction, such as a vacuum dressing
  • A vasoconstrictor, such as adrenaline.

What is the treatment for Koebner phenomenon?

  • Elective surgery/procedures are ideally performed while skin disease is stable or in remission.
  • Active systemic treatment of psoriasis may suppress the Koebner phenomenon.
  • A bland ointment may be inhibitory but topical corticosteroids have not been shown to prevent Koebner phenomenon.

Treatment for the cutaneous lesions arising from the Koebner phenomenon depends on the associated skin condition.

See smartphone apps to check your skin.
[Sponsored content]

 

Related information

 

References

  • Ueki H. Koebner phenomenon in lupus erythematosus with special consideration of clinical findings. Autoimmun Rev. 2005 Apr;4(4):219-23. Epub 2004 Dec 18. PubMed
  • Sagi L, Trau H. The Koebner phenomenon. Clin Dermatol. 2011 Mar-Apr;29(2):231-6. doi: 10.1016/j.clindermatol.2010.09.014. PubMed.
  • van Geel N, Speeckaert R, De Wolf J, Bracke S, Chevolet I, Brochez L, Lambert J. Clinical significance of Koebner phenomenon in vitiligo. Br J Dermatol. 2012 Nov;167(5):1017-24. doi: 10.1111/j.1365-2133.2012.11158.x. Epub 2012 Sep 5. PubMed
  • Camargo CM, Brotas AM, Ramos-e-Silva M, Carneiro S. Isomorphic phenomenon of Koebner: facts and controversies. Clin Dermatol. 2013 Nov-Dec;31(6):741-9. PubMed
  • Sagi L, Trau H. The Koebner phenomenon. Clin Dermatol. 2011 Mar-Apr;29(2):231-6. PubMed
  • Weiss G, Shemer A, Trau H. The Koebner phenomenon: review of the literature. J Eur Acad Dermatol Venereol. 2002 May;16(3):241-8. PubMed
  • Camargo CM, Brotas AM, Ramos-e-Silva M, Carneiro S. Isomorphic phenomenon of Koebner: facts and controversies. Clin Dermatol. 2013 Nov-Dec;31(6):741-9. doi: 10.1016/j.clindermatol.2013.05.012. PubMed
  • Alolabi N, White CP, Cin AD. The Koebner phenomenon and breast reconstruction: Psoriasis eruption along the surgical incision. Can J Plast Surg. 2011 Winter;19(4):143-4. PubMed.
  • Raychaudhuri SP, Jiang WY, Raychaudhuri SK. Revisiting the Koebner phenomenon: role of NGF and its receptor system in the pathogenesis of psoriasis. Am J Pathol. 2008 Apr;172(4):961-71. doi: 10.2353/ajpath.2008.070710. Epub 2008 Mar 18. PubMed
  • [Article in Croatian] Matović L, Poljacki M, Stojanović S, Subotić M. [Characteristics of the Koebner phenomenon in patients with psoriasis vulgaris]. Med Pregl. 2000 May-Jun;53(5-6):293-6. PubMed
  • Rubin AI et al. A listing of skin conditions exhibiting the koebner and pseudo-koebner phenomena with eliciting stimuli. J Cutan Med Surg. 2002 Jan-Feb;6(1):29-34. Epub 2002 Jan. PubMed
  • van Geel, N., Speeckaert, R., Taieb, A., Picardo, M., Böhm, M., Gawkrodger, D. J., Schallreuter, K., Bennett, D. C., van der Veen, W., Whitton, M., Moretti, S., Westerhof, W., Ezzedine, K., Gauthier, Y. and on behalf of the other VETF members (2011), Koebner’s phenomenon in vitiligo: European position paper. Pigment Cell – Melanoma Research, 24: 564–573. doi: 10.1111/j.1755-148X.2011.00838.x. Journal

On DermNet NZ

Books about the skin